Read + Share
Amedeo Smart
Independent Medical Education
Yen FS, Wang SI, Hwu CM, Haung CW, et al. Comparative risk of rheumatoid arthritis between glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors in type 2 diabetes. J Autoimmun 2025;157:103493.PMID: 41110425
Email
LinkedIn
Privacy Policy